课题基金 / 基金详情

Imaging epigenetics of Alzheimer's Disease

Imaging epigenetics of Alzheimer's Disease
阿尔茨海默病的影像表观遗传学
批准号:
9230612
负责人:
LIANA G APOSTOLOVA
金额:
$14.47万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2019-04-30

项目摘要

项目成果

LIANA G APOSTOLOVA的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):这项K02提案的短期目标是:1)通过增加高通量全基因组表观遗传学成分,扩大申请人的主动成像遗传学R01的范围;2)积极寻求统计遗传学和表观遗传学领域的额外培训;以及3)与著名的统计和成像遗传学专家建立新的和加强现有的合作。K02奖项的长期目标是支持申请者的科学事业,并进一步促进她成长为AD领域一名多产和非常成功的独立调查员。申请人已经制定了一项积极的研究计划,重点是AD的成像遗传生物标记物。她最近资助的R01奖研究了认知正常和前驱AD受试者的前瞻性纵向队列中临床、影像和转录相关疾病相关特征之间的关系。这项提议所包含的科学目标是扩大实验的范围,将新获得的表观遗传学数据包括在内。短期的科学目标是将表观遗传学与来自亲本R01的基因组、转录、临床和成像数据相结合,以阐明表观遗传学对基因表达、脑萎缩、脑淀粉样变性和疾病风险的影响。R01和K02的长期科学目标是确定与疾病相关的新途径和治疗靶点。为了确保拟议工作的成功,申请者将得到在高度相关的领域和方法方面具有专门知识的杰出合作者的支持。
英文摘要
DESCRIPTION (provided by applicant): The short term objectives of this K02 proposal are: 1) to expand the scope the applicant's active imaging genetic R01 by adding a high-throughput genome-wide epigenetic component; 2) to actively seek additional training in the areas of statistical genetics and epigenetics; and 3) to establish new and enhance existing collaborations with prominent statistical and imaging genetics experts. The long-term objective of the K02 award is to bolster the applicant's scientific career and to further facilitate her growth into a prolific and highly successful independent investigator in the AD field. The applicant has developed an active research program focused on the imaging genetic biomarkers of AD. Her recently funded R01 award studies the associations between clinical, imaging and transcriptomic disease-associated traits in a prospective longitudinal cohort of cognitively normal and prodromal AD subjects. The objective of the science integral to this proposal is to expand the scope of the experiments to include newly acquired epigenetic data. The short-term scientific goals are to integrate epigenetics with the genomic, transcriptomic, clinical and imaging data from the parent R01 in order to elucidate the epigenetic effects on gene expression, brain atrophy, brain amyloidosis and disease risk. The long-term scientific goals of the R01 and K02 are to identify novel disease-associated pathways and therapeutic targets. To ensure the success of the proposed work, the applicant will be supported by a diverse group of distinguished collaborators with expertise in highly relevant fields and methods.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Core
Clinical Core
Clinical Core
Leveraging Neuroimaging Biomarkers to Understand the Role of Social Networks in Alzheimer's Disease
  • 批准号:
    10426092
  • 项目类别:
  • 资助金额:
    $67.6万
  • 财政年份:
    2018
  • 负责人:
    LIANA G APOSTOLOVA
  • 依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究